In the present work we studied the antiviral activity of the home library of monoterpenoid
derivatives using the pseudoviral systems of our development, which have glycoproteins of …

The COVID-19 pandemic has led to the search for new molecules with antiviral activity
against SARS-CoV-2. The entry of the virus into the cell is one of the main targets for …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a major public health issue. The spike (S) protein mutation …

In this work, we evaluated the antiviral activity of Arbidol (Umifenovir) against SARS-CoV-2
using a pseudoviral system with the glycoprotein S of the SARS-CoV-2 virus on its surface …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has provoked a global health crisis due to the absence of a …

WHO has declared the outbreak of COVID-19 as a public health emergency of international
concern. The ever-growing new cases have called for an urgent emergency for specific anti …

Background Targeting viral cell entry proteins is an emerging therapeutic strategy for
inhibiting the first stage of SARS-CoV-2 infection. In this study, 106 bioactive terpenoids from …

Even after one year of its first outbreak reported in China, the coronavirus disease 2019
(COVID-19) pandemic is still sweeping the World, causing serious infections and claiming …

The world is currently witnessing the spread of the deadly severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) that causes the coronavirus disease 2019 (COVID …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a virus belonging to the
Coronavirus family, is now known to cause Coronavirus Disease (Covid-19) which was first …